A former SpaceX executive warns of Beijing’s hypersonic weapons amid a $13 billion defense startup launch, per Fortune.
The U.S. And China are set for trilateral talks on APEC sidelines, with Beijing emphasizing shared responsibility for global peace, SCMP reports.
China's biotech sector faces a setback after the FDA rejects a cancer drug invented in China, marking a blow to Beijing’s tech ambitions, FT notes.
People were searching for this story in 3 of the 54 countries E14 follows on Google Trends. Rank = its place among the searches that trended in that country within four hours of it.
E14 places every story on a stack of fifteen floors, from the fields under everything to the planet acting as one. This one sits on E11, organizations; the pressure it names: defense startup launch. Its words also reach E12 states.
Here it is a dynamic between organizations and states: former SpaceX executive, $13 billion defense startup launch and China's biotech sector (E11 organizations), with trilateral talks, APEC sidelines and global peace (E12 states).
The floor of companies and infrastructure. In this briefing: former SpaceX executive, $13 billion defense startup launch, China's biotech sector.
The floor of states and force. In this briefing: trilateral talks, APEC sidelines, global peace.